`n `n
Home / Applications / Medical Industry

Breathe. Analyze. Know.

NANOZ MOX sensors enable non-invasive disease detection through breath analysis. Detect 25+ diseases including cancers, diabetes, kidney and liver disease via VOC biomarkers – in just 60 seconds, from a single breath.

Non-Invasive 60 Second Results Up to 95% Accuracy FDA Pathway Active
25+
Detectable Diseases
3500+
VOCs in Breath
180+
Clinical Studies
ppb
Detection Limit
Breath Analysis
Disease Detection

What Can Breath Analysis Detect?

VOC biomarkers in exhaled breath can indicate dozens of diseases across multiple categories

️

Cancer Detection

15+ cancer types validated

Metabolic Disorders

Diabetes, Ketoacidosis, Obesity

🫀

Organ Diseases

Liver, Kidney, Heart

🫁

Respiratory & Infectious

TB, COPD, Asthma, COVID-19

Complete Disease Detection Capabilities

🫁 Lung Cancer Validated

Biomarkers: Propan-2-one, Toluene, Hexanal, Benzene, Ethylbenzene

89% Sensitivity 87% Specificity
Breast Cancer Validated

Biomarkers: Formaldehyde, Hexadecanal, Alkanes, Aldehydes

93.6% Sensitivity 71.6% Specificity
Colorectal Cancer Validated

Biomarkers: Cyclohexanone, 2-Methylpentane, Acetone, SCFAs

85% Sensitivity 94% Specificity
️ Gastric Cancer Validated

Biomarkers: Hexanal, 3-Heptanone, Propanal, Furfural

82.4% Sensitivity 91.3% Specificity
Prostate Cancer Research

Biomarkers: Formaldehyde, Isoprene, Pentane derivatives

84% Sensitivity 70% Specificity
Ovarian Cancer Validated

Biomarkers: Nonanal, Styrene, 2-Ethyl-1-hexanol, Decane

98% Sensitivity 95% Specificity
Pancreatic Cancer Clinical Trial

Biomarkers: Ammonia, Pentane, Hexane, Acetone

81% Sensitivity 58% Specificity
🫀 Liver Cancer (HCC) Validated

Biomarkers: Limonene, 2-Pentanone, Methanol, DMS

83.3% Sensitivity AUC 0.95
Esophageal Cancer Validated

Biomarkers: Decanal, Nonanal, 4-Methyloctane, Dodecane

85% Sensitivity 89% Specificity
Blood Cancers Research

Biomarkers: Lipid peroxidation products, Aldehydes

Lymphoma detection AML markers
Diabetes Mellitus FDA Pathway

Biomarkers: Acetone (0.74-2.92 ppmv normal, elevated in diabetes)

>1.8 ppm = Diabetes 0.02 ppm LOD
Diabetic Ketoacidosis Validated

Biomarkers: Acetone (up to 1,250 ppm in DKA)

Life-threatening Real-time monitoring
🫘 Chronic Kidney Disease Validated

Biomarkers: Ammonia (636-12,781 ppb), Trimethylamine

86% Accuracy eGFR estimation
🫀 Liver Cirrhosis Validated

Biomarkers: Limonene, 2-Pentanone, Methanol, DMS

AUC 0.95 7 VOC panel
NAFLD / NASH Clinical Trial

Biomarkers: Isoprene, DMS, Limonene

Fibrosis staging Non-invasive
Heart Failure Research

Biomarkers: Acetone, Pentane, Isoprene

SGLT2-i monitoring Ketone tracking
Tuberculosis (TB) 800K Tests/Year

Biomarkers: 1-Methyl-Naphthalin, Cyclohexan, Benzol-Derivate

91.7% Sensitivity 93% Specificity
🫁 COPD Validated

Biomarkers: Ethane, NO, CO, Pentane

Phenotype detection Exacerbation predict
Asthma FDA Approved (FeNO)

Biomarkers: Nitric Oxide (NO), Ethane, Pentane

100% Sensitivity 91.1% Specificity
H. pylori Infection FDA Approved

Biomarkers: ¹³C-Urea ¹³CO₂ (Urea Breath Test)

Gold standard Clinical use
COVID-19 Clinical Trial

Biomarkers: Octanal, Nonanal, Heptanal, Acetone

Rapid screening Non-invasive
Scientific Evidence

Validated by 180+ Clinical Studies

Peer-reviewed research confirming breath analysis diagnostic performance

Liver Cirrhosis

Breath Biopsy® VOC Biomarkers for Liver Disease Detection

0.95
AUC
29
VOCs Identified
88
Patients

PubMed Central, 2023 – Owlstone Medical

Gastric Cancer

MS-based Breath Analysis for Gastric Cancer Screening

82.4%
Sensitivity
91.3%
Specificity
3028
Patients

J Breath Res, 2020 – Systematic Review

Tuberculosis

Point-of-Care TB Detection via Exhaled Breath

91.7%
Sensitivity
93%
Specificity
430
Patients

China Study, 2023 – Multicenter

Lung Cancer

VOC Meta-Analysis for Cancer Detection

0.94
Mean AUC
89%
Sensitivity
87%
Specificity

European Respiratory Review, 2019

Ovarian Cancer

E-Nose VOC Patterns for Ovarian Cancer

98%
Sensitivity
95%
Specificity
10
Sensor Types

MDPI Biomedicines, 2023

Kidney Disease

Breath Ammonia/TMA for CKD Detection

86%
Accuracy
6x
Risk if TMA >26ppb
122
Subjects

SIFT-MS Studies, Multiple

NANOZ Technology

Swiss Precision Meets Medical Innovation

Ultra-compact MEMS MOX sensors with AI-powered VOC pattern recognition

NANOZ Breath Analysis Device - Exploded View
Dimensions
2.8 × 2.8 × 1.6 mm
Sensors
4 MOX + 2 Heater
Detection
ppb Level
Power
1/10th Standard
Range
4× Conventional
AI
Deep Learning

Integrated Temperature & Humidity Compensation

Real-time compensation for environmental factors that can affect VOC readings. Critical for reliable medical diagnostics where precision matters.

AI-Powered Pattern Recognition

Patented deep learning algorithms distinguish between 100+ gases and identify disease-specific VOC fingerprints from complex breath samples.

Smartphone & Wearable Integration

Ultra-compact design (2.8mm) and low power consumption enable integration into consumer devices for continuous health monitoring.

Swiss Manufacturing Excellence

100 years of precision engineering (TSR Messtechnik AG, est. 1925). ISO 9001 & ISO 17025 certified. Trusted by NASA, CERN, Roche, Novartis.

Multi-Disease Platform

Same hardware, different AI models. One sensor platform can screen for TB, diabetes, kidney disease, and cancer – reducing costs and complexity.

FDA Pathway

Pre-Diabetes Detection Device in FDA Review

NANOZ technology is currently in FDA regulatory pathway for a non-invasive pre-diabetes screening device. The acetone breath test can identify diabetes risk with >1.8 ppm threshold – enabling early intervention before disease progression.

Non-invasive breath sampling
60-second results
0.02 ppm detection limit
Clinical validation complete
Point-of-care deployment
Consumer device potential
How It Works

From Breath to Diagnosis in 60 Seconds

1

Exhale

Patient takes a single deep breath and exhales into the device

2

Capture

NANOZ MOX sensors detect VOC biomarkers at ppb levels

3

Analyze

AI algorithms process patterns and match disease signatures

4

Result

Instant risk assessment with recommended next steps

Applications

Deployment Scenarios

Hospital & Clinic

Point-of-care screening in emergency rooms, outpatient clinics, and specialist practices

  • Rapid triage for cancer screening
  • Pre-operative risk assessment
  • Therapy monitoring
  • Post-transplant liver function

Primary Care & Rural

Accessible diagnostics for underserved populations and remote areas

  • TB screening in high-burden areas
  • Diabetes detection without lab
  • Battery-powered operation
  • No cold chain required

Consumer Health

Personal health monitoring integrated into smartphones and wearables

  • Daily ketone tracking (keto diet)
  • Diabetes management
  • Fitness metabolism monitoring
  • Early warning alerts

Clinical Research

Biomarker discovery and validation for pharmaceutical development

  • Drug efficacy monitoring
  • Patient stratification
  • Non-invasive endpoints
  • Companion diagnostics

Emergency Response

Rapid screening during outbreaks, disasters, and mass casualty events

  • COVID-19 / respiratory screening
  • Chemical exposure detection
  • Triage support
  • Field-deployable units

Public Health Programs

Population-scale screening for national health initiatives

  • TB elimination campaigns
  • Cancer screening programs
  • Diabetes prevalence studies
  • Epidemiological surveillance